Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Oncolytics Biotech Inc. (ONCY) had Operating Cash Flow per Share of $-0.06 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-9.24M |
|
-- |
|
-- |
|
$9.28M |
|
$-9.28M |
|
$0.04M |
|
$-9.24M |
|
$-9.24M |
|
$-9.24M |
|
$-9.24M |
|
$-9.24M |
|
$-9.24M |
|
$-9.28M |
|
$-9.27M |
|
112.29M |
|
112.29M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$7.49M |
|
$0.22M |
|
$0.67M |
|
$8.16M |
|
$5.42M |
|
-- |
|
$7.87M |
|
$13.29M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
116.13M |
|
| Cash Flow Statement Financials | |
$-7.29M |
|
$-0.01M |
|
$7.61M |
|
$5.20M |
|
$5.49M |
|
$0.29M |
|
$2.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
180.18% |
|
180.18% |
|
-113.26% |
|
180.18% |
|
$-0.04 |
|
$-0.07 |
|
|
Operating Cash Flow per Share |
$-0.06 |